Clinical trial
Oral Triiodothyronine Normalizes T3 Levels After Surgery For Pediatric Congenital Heart Disease
NCT01780584 is registered in ClinicalTrials.gov with National Cardiovascular Center Harapan Kita Hospital Indonesia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Oral Triiodothyronine Normalizes T3 Levels After Surgery For Pediatric Congenital Heart Disease
- Lead sponsor
- National Cardiovascular Center Harapan Kita Hospital Indonesia
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 30, 2010
- Completion date
- October 31, 2010
- Enrollment
- 45 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
low t3 syndrome